Table 4

Statin use in gastric cancer patients
Variables Statin User Non-Statin User P value
N % N %
Sex
   Men 71 71.7 681 77.0 .2365
   Women 28 28.3 203 23.0
Lauren classification
   Intestinal 22 22.2 283 33.8 .1351
   Diffuse 67 67.7 518 61.9
   Mixed 4 4.0 36 4.3
   Missing information 6 6.0 47 5.3
Pathology
   W/D adenocarcinoma 26 26.3 142 16.0 .1461 (adenoca vs signet ring)
   M/D adenocarcinoma 39 39.4 357 40.3
   P/D adenocarcinoma 21 21.2 251 28.3
   Signet ring cell carcinoma 13 13.1 134 15.4
Smoking
   Never-smoker 51 51.5 391 44.2 .3037
   Smoker 47 47.5 472 53.4
   Missing information 1 1 21 2.4
Location
   Cardia 6 6.1 51 5.8
   Body ~ antrum 91 91.9 817 92.5 .9660
   Whole, multifocal 2 2.0 15 1.7
   Missing information 0 0 1 0.1
Helicobacter Pylori
   Present 44 44.4 331 37.4 .1897
   Absent 41 41.4 405 45.8
   Missing information 14 14.2 148 16.7
Stage
   Localized (stage I/II) 81 81.8 642 72.6 .0400
   Advanced (stage III/IV) 16 16.2 226 25.6
   Missing information 2 2.0 16 1.8

*Abbreviations: W/D well differentiated, M/D moderately differentiated, P/D poorly differentiated.

Lee et al.

Lee et al. BMC Cancer 2012 12:596   doi:10.1186/1471-2407-12-596

Open Data